UC San Diego SearchMenu

Guidance from Sponsors and Research Partners Regarding the Impact of COVID-19 on Research

Find guidance from Sponsors and Research Partners regarding the impact of COVID-19 on Research.

For a full list of frequently asked questions regarding COVID-19-related issues for contracts and grants, visit our FAQ page here.

For broader information on the continuity of research impacted by COVID-19, go to Office of Research Affairs (ORA)'s COVID-19: Continuity of Research page.

Flexibilities allowed by Sponsors for charging research expenditures to federal grants and contracts: 

At this time, campuses should continue to charge salaries, stipends, and benefits to currently active awards consistent with the UC policy of paying salaries from all funding sources, federal and nonfederal. Likewise costs related to the cancellation of events, travel, or other authorized activities due to the COVID-19 crisis, may charge these costs to their award if they would have otherwise been allowable. Please ensure appropriate records and cost documentation are maintained to substantiate the charging of any cancellation or other fees related to interruption of operations or services.

Recently President Napolitano announced all employees are eligible to receive a one-time allotment of up to 128 hours of paid administrative leave in recognition of the extraordinary demands staff and their family members are facing as a result of the impacts of the coronavirus on the UC community. This employee benefit is an allowable cost could be charged to federal grants and contracts consistent with other employee benefits. However, it is important that you verify if your sponsor offer such same flexibility.

UCOP Guidance: Charging grants and contracts costs to Federal sponsored awards during COVID-19 (pdf) (March 24, 2020)

Summary of Sponsor Guidance on impact of COVID-19 on Research Grants (March 26, 2020)

Guidance from Sponsors & Research Partners

The following guidance is updated as received:

Expand all

Federal

Office of Management and Budget (OMB)

Note that this guidance is for federal agencies. Agency-specific guidance will be based on these memoranda and will be posted on this page when received.

Corporation for National and Community Service (CNCS)

Department of Health and Human Services (DHHS)

National Institutes of Health (NIH)

  Department of Defense (DOD)
  • Naval Research Laboratory (NRL): The Chief of Naval Research (CNR) has directed all inbound and outbound   Outside [the]   CONtiguous   United   States (a.k.a OCONUS) both essential and non-essential official travel under a NRL contract be canceled or suspended due to escalating concerns over the global spread of the Coronavirus (COVID-19) unless an exception is granted by the CNR. If you have any additional questions, please contact your Contract and Grant Officer. (March 13, 2020)

Department of Energy (DOE)

Food and Drug Administration (FDA)

Institute of Museum and Library Services

National Aeronautics and Space Administration (NASA)

National Institute of Standards and Technology (NIST)

NIST will be doing its part to help PIs continue their NIST-funded research/project. The NIST Grants Office continues to operate during normal business hours with staff working remotely.  The best way to contact your NIST Grants Officer and Grants Specialist is via email.  NIST also recommends that grantees review the Memoranda issued by OMB:  M-20-17 (March 19, 2020),  M-20-13 (March 12, 2020),  M-20-11 (March 9, 2020).

National Science Foundation (NSF)

U.S. Agency for International Development (USAID)

U.S. Department of Agriculture (USDA)

National Institute of Food and Agriculture (NIFA): 

U.S. Department of Justice - Office of Justice Programs

National Oceanic and Atmospheric Administration

Administration of Children and Families

Centers for Disease Control and Prevention (CDC)

National Laboratories

Institute of Museum and Library Services (IMLS)

Substance Abuse and Mental Health Services Administration (SAMHSA)

Department of Education

Health Resources and Services Administration (HRSA)

Non-Profit

  • Health Research Alliance [healthra.org] (HRA) is a collaborative member organization of non-profit research funders. They represent over 85 non-profit funders. HRA solicited feedback from its members on how they are preparing for or responding to COVID-19 [healthra.org], and combined this data with information compiled by a team at the Simons Foundation. They’ve consolidated the information into one spreadsheet [healthra.org], which contains data from 80 non-profit sponsors.

  • Cures Within Reach: All proposal deadlines extended to April 3, 2020.

  • The Andrew W. Mellon Foundation: Active Mellon Grants - Please send an email to program staff to initiate a COVID-19 related modification. Please also note that the HESH program will be allowing a three-month grace period for reporting on all grants.

  • The Retirement Research Foundation (RRF) - Foundation for Aging: If you are a current grantee and your organization needs a no-cost extension, budget re-allocation, or other adjustment, contact your program officer to discuss your particular situation.

  • Gordon and Betty Moore Foundation: As researcher start to understand how the current conditions may impact work with the foundation, please let the Moore Foundation know. Moore Foundation contacts will continue to provide the time, flexibility, and resources you need to achieve shared goals.

  • GOG Foundation: The situation is evolving from day to day, so please continue to monitor our website for information. Please feel free to reach out to us directly with any related questions at info@gog.org.

  • Conquer Cancer, the ASCO Foundation: Resources to support clinicians, the cancer care delivery team, and patients with cancer. Please contact our Grants& Awards team at grants@conquer.org with questions. We will be flexible: with deadlines for grant reports or other deliverables; process grant payments as scheduled and communicate any delays; and revisit any grant objectives, timelines, and terms, to ensure that you can focus on more emergent needs at this time.

  • The Packard Foundation Message on the flexibilities for projects impacted by COVID-19, including extension on reporting requirements and prior approval requirements. (March 19, 2020)

  • Council on Foundations (COF): A CALL TO ACTION: Philanthropy's Commitment During COVID-19: Join the Hundreds of Organizations who have Signed the Pledge!
    • Note from UCSD's Foundation Relations Team: During this difficult time, many of our foundation partners are expressing their support and understanding to grantees and potential applicants who have been impacted by the current public health crisis. The health and safety of faculty, postdocs, students and administrators, remains a top priority for these foundations, and this sentiment is being reflected in their guidance to discontinue and/or postpone work that will put anyone at risk. Our foundation partners also understand that travel restrictions, meeting cancellations and campus closures may make it impossible or difficult to fulfill grant activities. If there are any major concerns, unexpected costs, or emergency needs for your research, the best course of action is to reach out directly to the program officer with whom you have been working. Please know that the Foundation Relations team is here to help coordinate outreach to foundations as well. You can email us at foundationrelations@ucsd.edu with any questions or requests for support. We have been in touch with many foundations and are tracking changing deadlines for current and future grant opportunities as they come out.
  • MacArthur Foundation COVID-19 response and support for grantees
  • HHMI Medically Trained Scientists Program COVID-19 suspension

Industry

  • DCS Corporation: DCS Subcontractors who are able to perform their work at home (or alternate location) should do so if they exhibit any symptoms of COVID-19 or have family members who are symptomatic.

UC & California

UCOP

University of California Grant Programs

 California Institute for Regenerative Medicine (CIRM)

  • For Clinical, Translational and Infrastructure awardees CIRM will not terminate awards for operational milestone delays due to the impact of COVID-19.  No formal request to CIRM is required.  For those of you who are running clinical trials, the FDA has issued a new guidance document entitled, FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic Guidance for Industry, Investigators, and Institutional Review Boards, March 2020 which is linked for your convenience. (March 20, 2020)

  • Inception, Quest and other non-milestone research awards will be allowed no-cost extensions beyond the allowable limit in the Notice of Award.  For these award types that require a no-cost extension, awardees should submit a Prior Approval request 30 days prior to the original project end date via the CIRM Grants Management System. (March 20, 2020)

State of California

UCSD IRB

County of San Diego

California Strategic Growth Council

Research Partners: NCURA & COGR

Expand all